Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 3;12:967000. doi: 10.3389/fonc.2022.967000

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Li, Chen, Zhou, Maimaitirexiati, Yan, Li, Maimaitiyimin, Zhou, Ren, Liu, Mainike, Zhou and Ding

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

LncRNA SCAMP1 overexpression promotes cell viability and colony formation via miR-26a-5p. (A): CCK8 assays showed that overexpression of lncRNA SCAMP1 abolished miR-26a-5p mimics-mediated inhibition of cell viability in MG63 cells. (B): CCK8 assays showed that inhibition of miR-26a-5p enhanced viability of U2OS cells, which was abrogated by shR-SCAMP1 transfection. (C): Left panel: Colony formation assays showed that in SCAMP1-overexpressing MG63 cells, miR-26a-5p mimics-mediated suppression of colony formation was abolished in MG63 cells. Right panel: quantitative data is shown for colony formation of MG63 cells. (D): Left panel: Colony formation assays showed that in U2OS cells with shR-SCAMP1 transfection, miR-26a-5p-inhibitor-induced colony formation was blocked. Right panel: quantitative data is shown for colony formation of U2OS cells. miR-26a inh: miR-26a inhibitors. **p<0.01; ***p<0.001 vs. control group.